Arama Sonuçları - Robert Lindblad

Sonuçları Daraltın
  1. 1
    A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy

    A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy Yazar: Robert A. Wood, Jennifer S. Kim, Robert Lindblad, Kari C. Nadeau, Alice K. Henning, Peter Dawson, Marshall Plaut, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy

    Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy Yazar: Anna Nowak‐Węgrzyn, Robert A. Wood, Kari C. Nadeau, Jacqueline A. Pongracic, Alice K. Henning, Robert Lindblad, Kirsten Beyer, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology

    A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology Yazar: Roger D. Weiss, Jennifer Sharpe Potter, Scott E. Provost, Zhen Huang, Petra Jacobs, Albert Hasson, Robert Lindblad, Hilary S. Connery, Kristi Prather, Walter Ling

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis

    Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis Yazar: Peter S. Creticos, John T. Schroeder, Robert G. Hamilton, Susan Balcer-Whaley, A.P. Khattignavong, Robert Lindblad, Henry Li, Robert L. Coffman, Vicki L. Seyfert, Joseph Eiden, David H. Broide

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy

    Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy Yazar: Pamela A. Frischmeyer‐Guerrerio, Madhan Masilamani, Wenjuan Gu, Erica Brittain, Robert A. Wood, Jennifer Kim, Kari C. Nadeau, Kirsi M. Järvinen, Alexander Grishin, Robert Lindblad, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    A reproducible immunopotency assay to measure mesenchymal stromal cell–mediated T-cell suppression

    A reproducible immunopotency assay to measure mesenchymal stromal cell–mediated T-cell suppression Yazar: Debra D. Bloom, John M. Centanni, Neehar Bhatia, Carol A. Emler, Diana Drier, Glen Leverson, David H. McKenna, Adrian P. Gee, Robert Lindblad, Derek J. Hei, Peiman Hematti

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants

    Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants Yazar: Scott H. Sicherer, Robert A. Wood, Donald M. Stablein, Robert Lindblad, A. Wesley Burks, Andrew H. Liu, Stacie M. Jones, David M. Fleischer, Donald Y.M. Leung, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence

    Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence Yazar: Theresa Winhusen, Frankie Kropp, Robert Lindblad, Antoine Douaihy, Louise Haynes, Candace Hodgkins, Karen G. Chartier, Kyle M. Kampman, Gaurav Sharma, Daniel Lewis, Paul VanVeldhuisen, Jeff Theobald, Jeanine May, Gregory S. Brigham

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group

    Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group Yazar: A. Thomas McLellan, Joanna L. Starrels, Betty Tai, Adam J. Gordon, Richard L. Brown, Udi E. Ghitza, Marc N. Gourevitch, Jack B. Stein, Marla Oros, Terry Horton, Robert Lindblad, Jennifer McNeely

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Early epitope-specific IgE antibodies are predictive of childhood peanut allergy

    Early epitope-specific IgE antibodies are predictive of childhood peanut allergy Yazar: Maria Suprun, Scott H. Sicherer, Robert A. Wood, Stacie M. Jones, Donald Y.M. Leung, Alice K. Henning, Peter Dawson, A. Wesley Burks, Robert Lindblad, Robert Getts, Mayte Suárez‐Fariñas, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

    NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale Yazar: Joshua D. Lee, Edward V. Nunes, Patricia Novo, Genie L. Bailey, Gregory S. Brigham, Allan Cohen, Marc Fishman, Walter Ling, Robert Lindblad, Dikla Shmueli‐Blumberg, Don Stablein, Jeanine May, Dagmar Salazar, David Liu, John Rotrosen

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

    Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial Yazar: P. Todd Korthuis, Paula J. Lum, Pamela Vergara‐Rodriguez, Keith Ahamad, Evan Wood, Lynn E. Kunkel, Neal L. Oden, Robert Lindblad, James L. Sorensen, Virgilio Arenas, Doan Ha, Raúl N. Mandler, Dennis McCarty

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial

    Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial Yazar: A. Wesley Burks, Robert A. Wood, Stacie M. Jones, Scott H. Sicherer, David M. Fleischer, Amy M. Scurlock, Brian P. Vickery, Andrew H. Liu, Alice K. Henning, Robert Lindblad, Peter Dawson, Marshall Plaut, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy

    Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy Yazar: Scott H. Sicherer, Robert A. Wood, Donald M. Stablein, A. Wesley Burks, Andrew H. Liu, Stacie M. Jones, David M. Fleischer, Donald Y.M. Leung, Alexander Grishin, Lloyd Mayer, Wayne G. Shreffler, Robert Lindblad, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments

    Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments Yazar: Michael P. Bogenschutz, Dennis M. Donovan, Raúl N. Mandler, Harold I. Perl, Alyssa A. Forcehimes, Cameron Crandall, Robert Lindblad, Neal L. Oden, Gaurav Sharma, Lisa R. Metsch, Michael S. Lyons, Ryan McCormack, Wendy Macias‐Konstantopoulos, Antoine Douaihy

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial

    Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial Yazar: David M. Fleischer, A. Wesley Burks, Brian P. Vickery, Amy M. Scurlock, Robert A. Wood, Stacie M. Jones, Scott H. Sicherer, Andrew H. Liu, Donald M. Stablein, Alice K. Henning, Lloyd Mayer, Robert Lindblad, Marshall Plaut, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Oral Immunotherapy for Treatment of Egg Allergy in Children

    Oral Immunotherapy for Treatment of Egg Allergy in Children Yazar: A. Wesley Burks, Stacie M. Jones, Robert A. Wood, David M. Fleischer, Scott H. Sicherer, Robert Lindblad, Donald M. Stablein, Alice K. Henning, Brian P. Vickery, Andrew H. Liu, Amy M. Scurlock, Wayne G. Shreffler, Marshall Plaut, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy

    Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy Yazar: Edwin Kim, Tamara T. Perry, Robert A. Wood, Donald Y.M. Leung, M. Cecilia Berin, A. Wesley Burks, Christine B. Cho, Stacie M. Jones, Amy M. Scurlock, Scott H. Sicherer, Alice K. Henning, Peter Dawson, Robert Lindblad, Marshall Plaut, Hugh A. Sampson

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end‐points in clinical trials

    Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end‐points in clinical trials Yazar: Dennis M. Donovan, George E. Bigelow, Gregory S. Brigham, Kathleen M. Carroll, Allan Cohen, John G. Gardin, John A. Hamilton, Marilyn A. Huestis, John R. Hughes, Robert Lindblad, G. Alan Marlatt, Kenzie L. Preston, Jeffrey Selzer, Eugene Somoza, Paul Wakim, Elizabeth A. Wells

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research

    Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research Yazar: Amy M. Scurlock, A. Wesley Burks, Scott H. Sicherer, Donald Y.M. Leung, Edwin Kim, Alice K. Henning, Peter Dawson, Robert Lindblad, M. Cecilia Berin, Christine B. Cho, Wendy F. Davidson, Marshall Plaut, Hugh A. Sampson, Robert A. Wood, Stacie M. Jones

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: